Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGT-2168 vs clopidogrel to reduce upper gastrointestinal events in dual antiplatelet therapy
2007-005891-15Phase 3Terminated
- Sponsor
- Cogentus Pharmaceuticals
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clopidogrel + omeprazole in upper gastrointestinal bleeding (UGIB) and Peptic ulcer disease (PUD) (2 arms), sponsored by Cogentus Pharmaceuticals. Primary endpoint: Time to first upper gastrointestinal clinical event. Started Feb 2008; status: terminated.
02
Drugs
clopidogrel + omeprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on 2007-005891-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005891-15.